M
Mainstay Medical, led by a team of dedicated scientists, executives, engineers, and clinical experts, brings to you ReActiv8®, the first and only FDA-approved restorative treatment for mechanical chronic low back pain. RESTORE Control RESTORE Function RESTORE Stability ReActiv8 LIFE The Company was incorporated in Dublin, Ireland and headquartered in San Diego, CA. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands.
Investor insights
Funding rounds participated in
$125M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Medical Equipment Manufacturing
Sectors
Medical Equipment Manufacturing
Date founded
2008
Funding rounds raised
Total raised
$125M
from 3 investors over 1 rounds
M
Mainstay Medical raised $125M on March 26, 2024
Investors: Viking Global Investors, Gilde Healthcare and + 4 Other investors